MX2020011892A - Polinucleotidos para la amplificacion y deteccion de chlamydia trachomatis. - Google Patents

Polinucleotidos para la amplificacion y deteccion de chlamydia trachomatis.

Info

Publication number
MX2020011892A
MX2020011892A MX2020011892A MX2020011892A MX2020011892A MX 2020011892 A MX2020011892 A MX 2020011892A MX 2020011892 A MX2020011892 A MX 2020011892A MX 2020011892 A MX2020011892 A MX 2020011892A MX 2020011892 A MX2020011892 A MX 2020011892A
Authority
MX
Mexico
Prior art keywords
detection
polynucleotides
amplification
chlamydia trachomatis
trachomatis
Prior art date
Application number
MX2020011892A
Other languages
English (en)
Inventor
Daniel Capule
Andrea C Dedent
Matthew B Lee
Shuyuan Ma
Hédia Maamar
Dana Kelly Vanatta
Original Assignee
Talis Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Talis Biomedical Corp filed Critical Talis Biomedical Corp
Publication of MX2020011892A publication Critical patent/MX2020011892A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/682—Signal amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/10—Nucleotidyl transfering
    • C12Q2521/107—RNA dependent DNA polymerase,(i.e. reverse transcriptase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/101—Linear amplification, i.e. non exponential
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10—Detection mode being characterised by the assay principle
    • C12Q2565/101—Interaction between at least two labels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La invención proporciona métodos y composiciones para la detección de Chlamydia trachomatis en una muestra de prueba. Su presencia o ausencia en la muestra se determina mediante métodos de prueba basados en ácidos nucleicos que utilizan cebadores y/o sondas y/o balizas moleculares que se unen a los genes ribosomales 23S o transcripciones génicas.
MX2020011892A 2018-05-09 2019-05-09 Polinucleotidos para la amplificacion y deteccion de chlamydia trachomatis. MX2020011892A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862669236P 2018-05-09 2018-05-09
US15/976,733 US10450616B1 (en) 2018-05-09 2018-05-10 Polynucleotides for the amplification and detection of Chlamydia trachomatis
PCT/US2019/031439 WO2019217627A1 (en) 2018-05-09 2019-05-09 Polynucleotides for the amplification and detection of chlamydia trachomatis

Publications (1)

Publication Number Publication Date
MX2020011892A true MX2020011892A (es) 2021-02-22

Family

ID=68241766

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011892A MX2020011892A (es) 2018-05-09 2019-05-09 Polinucleotidos para la amplificacion y deteccion de chlamydia trachomatis.

Country Status (14)

Country Link
US (4) US10450616B1 (es)
EP (1) EP3790996A4 (es)
JP (2) JP7402180B2 (es)
KR (1) KR20210006964A (es)
CN (1) CN112368400A (es)
AU (1) AU2019265733A1 (es)
BR (1) BR112020022762A2 (es)
CA (1) CA3098140A1 (es)
CO (1) CO2020015231A2 (es)
MX (1) MX2020011892A (es)
PH (1) PH12020551880A1 (es)
SG (1) SG11202010697YA (es)
WO (1) WO2019217627A1 (es)
ZA (1) ZA202007173B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10450616B1 (en) 2018-05-09 2019-10-22 Talis Biomedical Corporation Polynucleotides for the amplification and detection of Chlamydia trachomatis
US10954572B2 (en) 2019-07-25 2021-03-23 Talis Biomedical Corporation Polynucleotides for the amplification and detection of Neisseria gonorrhoeae
US11008627B2 (en) 2019-08-15 2021-05-18 Talis Biomedical Corporation Diagnostic system
EP4025715A1 (en) * 2019-09-05 2022-07-13 Gen-Probe Incorporated Detection of chlamydia trachomatis nucleic acid variants
US11891662B2 (en) 2019-12-02 2024-02-06 Talis Biomedical Corporation Polynucleotides for amplification and detection of human beta actin
KR102392567B1 (ko) * 2021-11-30 2022-04-29 주식회사 에이아이더뉴트리진 클라미디아 진단용 조성물 및 다중 등온증폭 프라이머 세트, 그리고 이를 이용한 신속성, 정확성 및 휴대성이 향상된 키트와 진단키트를 통한 육안진단방법

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5155018A (en) 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
DE4321904B4 (de) 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
US5514551A (en) * 1994-10-14 1996-05-07 Gen-Probe Incorporated Compositions for the detection of Chlamydia trachomatis
EP0866071B1 (en) 1997-03-20 2004-10-20 F. Hoffmann-La Roche Ag Modified primers
US7572902B2 (en) * 1997-12-09 2009-08-11 Monsanto Technology Llc Nucleic acid molecules seq id No. 16372 and other molecules associated with plants
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
EP1815863A1 (en) 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of TLR3 agonists for the treatment of neurodegenerative disorders
EP2125034A4 (en) 2007-02-01 2010-01-27 Veridex Llc METHODS AND SUBSTANCES FOR IDENTIFYING THE ORIGIN OF AN UNKNOWN UNKNOWN MAIN CARCINOMA
JP4410268B2 (ja) 2007-03-28 2010-02-03 株式会社東芝 メチレンテトラヒドロ葉酸還元酵素（ｍｔｈｆｒ）の遺伝子型を検出するための核酸プライマーセット及び核酸プローブ
EP2514838B1 (en) * 2007-04-13 2017-12-06 Abbott Molecular Inc. Primer and probe sequences for detecting chlamydia trachomatis
WO2008156676A1 (en) * 2007-06-15 2008-12-24 President And Fellows Of Harvard College Methods and compositions for detecting and modulating o-glycosylation
JP2009000044A (ja) 2007-06-21 2009-01-08 Hitachi High-Technologies Corp 核酸増幅法
EP2218780B1 (en) 2007-10-19 2013-07-24 Eiken Kagaku Kabushiki Kaisha Nucleic acid amplification method, and reagent and reagent kit for use in the method
WO2010010951A1 (ja) 2008-07-24 2010-01-28 Kuroda Masahiko 子宮内膜症関連疾患の指標ｍＲＮＡの発現の検出方法およびそれに用いるプローブ
CN101831488A (zh) 2009-03-11 2010-09-15 孙星江 利用环介导等温扩增技术快速检测淋病奈瑟菌
GB0922097D0 (en) * 2009-12-17 2010-02-03 Atlas Genetics Ltd Microbial assay
CN101886122B (zh) 2010-05-10 2012-10-17 珠海市银科医学工程有限公司 环介导恒温扩增检测肺炎衣原体的方法及检测试剂盒
EP2388312A1 (en) 2010-05-17 2011-11-23 Curetis AG Universally applicable lysis buffer and processing methods for the lysis of bodily samples
JP2012085605A (ja) 2010-10-22 2012-05-10 Sony Corp 核酸増幅反応装置、核酸増幅反応装置に用いる基板、及び核酸増幅反応方法
WO2012054589A2 (en) 2010-10-22 2012-04-26 T2 Biosystems, Inc. Conduit-containing devices and methods for analyte processing and detection
JP5838550B2 (ja) * 2010-12-22 2016-01-06 東ソー株式会社 クラミジア・トラコマチスｒｎａの検出方法及び検出試薬
US20130017539A1 (en) * 2011-07-11 2013-01-17 Program For Appropriate Technology In Health Methods and compositions for chlamydia trachomatis diagnostic testing
CN108103145A (zh) 2011-10-31 2018-06-01 荣研化学株式会社 靶核酸的检测方法
US9074249B2 (en) 2012-06-04 2015-07-07 New England Biolabs, Inc. Detection of amplification products
US9809845B2 (en) 2012-08-06 2017-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and reagents for amplifying nucleic acids
WO2014036444A1 (en) 2012-08-30 2014-03-06 Abbott Laboratories Prame detection assays
US20140114215A1 (en) 2012-10-20 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Methods for Renal Neuromodulation and Associated Systems and Devices
CA2888949A1 (en) * 2012-10-20 2014-04-24 Selfdiagnostics Ou Method and its compositions for detection of nucleic acid target from biological samples and body fluids
EP2909338B1 (en) 2012-10-22 2018-08-15 Bayer CropScience NV Methods, compositions and devices for amplification of nucleic acids
US10329629B2 (en) * 2013-07-26 2019-06-25 Cepheid Methods of detecting chlamydia and gonorrhea and of screening for infection/inflammation based on genomic copy number
US10196684B2 (en) 2013-10-18 2019-02-05 California Institute Of Technology Enhanced nucleic acid identification and detection
GB201319180D0 (en) 2013-10-30 2013-12-11 Mast Group Ltd Nucleic acid probe
CN106661600B (zh) 2014-07-16 2021-04-06 唐恩生物科技股份有限公司 用于扩增核酸样品的等温方法
JP7055020B2 (ja) 2014-11-05 2022-04-15 カリフォルニア インスティテュート オブ テクノロジー 薬剤に対する生物の応答のマイクロ流体測定
US10227661B2 (en) 2014-11-21 2019-03-12 GeneWeave Biosciences, Inc. Sequence-specific detection and phenotype determination
WO2016105508A2 (en) 2014-12-23 2016-06-30 California Institute Of Technology Devices and methods for autonomous measurements
US9657353B2 (en) 2015-06-26 2017-05-23 Great Basin Scientific, Inc. Specific detection of organisms derived from a sample
JP6651735B2 (ja) * 2015-08-21 2020-02-19 東ソー株式会社 クラミジア・トラコマチスを検出するためのオリゴヌクレオチドプライマーおよび当該プライマーを用いたクラミジア・トラコマチスの検出方法
KR20180111802A (ko) * 2015-12-18 2018-10-11 셀프디아그노스틱스 도이칠란트 게엠베하 성적으로 전염되는 전염성 병원균의 검출 방법
CA3022947A1 (en) * 2016-05-04 2017-11-09 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications
CN110177887A (zh) * 2016-11-10 2019-08-27 达丽斯生物医学公司 用于扩增和检测沙眼衣原体的多核苷酸
WO2018089943A1 (en) 2016-11-10 2018-05-17 Slipchip Corporation Probe detection of loop-mediated amplification products
EP3538538A4 (en) 2016-11-10 2020-11-04 Talis Biomedical Corporation POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE
CN107099618A (zh) 2017-05-03 2017-08-29 上海速创诊断产品有限公司 一种用于检测泌尿生殖道致病微生物的lamp引物组合物及其相关应用
US10450616B1 (en) * 2018-05-09 2019-10-22 Talis Biomedical Corporation Polynucleotides for the amplification and detection of Chlamydia trachomatis

Also Published As

Publication number Publication date
PH12020551880A1 (en) 2021-07-12
US20190345541A1 (en) 2019-11-14
EP3790996A1 (en) 2021-03-17
US20210301325A1 (en) 2021-09-30
EP3790996A4 (en) 2022-06-01
US10450616B1 (en) 2019-10-22
JP2024028922A (ja) 2024-03-05
WO2019217627A1 (en) 2019-11-14
BR112020022762A2 (pt) 2021-03-02
KR20210006964A (ko) 2021-01-19
US20230073971A1 (en) 2023-03-09
JP7402180B2 (ja) 2023-12-20
US11326214B2 (en) 2022-05-10
CO2020015231A2 (es) 2020-12-21
US20200002752A1 (en) 2020-01-02
CA3098140A1 (en) 2019-11-14
AU2019265733A1 (en) 2020-12-24
ZA202007173B (en) 2024-04-24
JP2021522818A (ja) 2021-09-02
SG11202010697YA (en) 2020-11-27
CN112368400A (zh) 2021-02-12

Similar Documents

Publication Publication Date Title
MX2020011892A (es) Polinucleotidos para la amplificacion y deteccion de chlamydia trachomatis.
WO2018089942A8 (en) Polynucleotides for the amplification and detection of chlamydia trachomatis
AU2017257624A1 (en) Hybridization chain reaction methods for in situ molecular detection
WO2018136562A3 (en) Compositions and methods for immune repertoire sequencing
NZ723570A (en) Compositions and methods for quantifying a nucleic acid sequence in a sample
RU2017101174A (ru) Набор или устройство для обнаружения рака печени и способ обнаружения
BR112017008082A2 (pt) composições e métodos para detectar um vírus de rna
MX2021000946A (es) Metodo de deteccion de acido nucleico.
SG10201808952WA (en) Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications
WO2016059474A3 (en) Sequence conversion and signal amplifier dna having poly dna spacer sequences and detection methods using same
EA201200907A1 (ru) Способ обнаружения генетического материала chlamydia trachomatis, зонд нуклеиновой кислоты (варианты), прямой (варианты) и обратный (варианты) праймеры пцр, их содержащий компонент пцр, содержащий вышеуказанный компонент набор и способ обнаружения генетического материала pectobacterium atrosepticium
EP4328327A3 (en) Reporter dye for isothermal nucleic acid amplification, isothermal-based dual functional oligonucleotide containing quencher, and method for nucleic acid amplification and measurement using same
CL2022000126A1 (es) Polinucleótidos para la amplificación y detección de neisseria gonorrhoeae
RU2017102991A (ru) Композиции и способы обнаружения и анализа микробактерии туберкулеза (mycobacterium tuderculosis)
UA110815C2 (uk) Детекція нуклеїновокислотної послідовності-мішені в аналізі із розщепленням та подовженням рто
GB2556001A (en) Diagnostic kits
WO2013187958A8 (en) Methods and compositions for detection of legionella
ATE514794T1 (de) Zusammensetzungen und verfahren für den nachweis von enterokokken-nukleinsäuren
BR112016030008A2 (pt) método para a detecção de infecção por pegivirus humano 2 em um indivíduo, para a detecção de ácido nucleico de pegivirus humano 2 e para a detecção de pegivirus humano 2 em uma amostra, e, composição
WO2017120216A3 (en) Methods and compositions for detecting candida species
WO2014186734A3 (en) Methods and compositions for detection of legionella
WO2015026757A3 (en) Sequences and their use for detection of salmonella enteritidis and/or salmonella typhimurium
EA201401195A1 (ru) Набор реагентов для выявления днк chlamydia trachomatis и его применение
ES2784357T3 (es) Composiciones y procedimientos para la detección de Mycobacterium tuberculosis
PL417771A1 (pl) Para oligonukleotydowych starterów do wykrywania genu karłowatości Dw2 i sposób identyfikacji molekularnej genu Dw2 warunkującego dominującą karłowatość żyta (Secale cereale L.)